Artificial Intelligence Technology Solutions, Inc. (AITX) announced that its subsidiary Robotic Assistance Devices, Inc. (RAD) achieved a 12.4% increase in billed recurring monthly revenue over two months, reaching $663,906 in October 2026. This growth was entirely driven by its established stationary device portfolio, with future growth expected from products ROAMEO, SARA, and RAIA. The increase reflects the company's focus on expanding recurring revenue while reducing operating costs, aiming to achieve positive operational cash flow. These preliminary figures highlight RAD's strengthening subscription base and strategic prioritization of engineering resources toward future growth pillars.
AITX’s RAD reported a 12.4% increase in billed recurring monthly revenue over two months, reaching $663,906 in October 2026. For readers following Technology-sector US stocks on Pluang, here is the market snapshot as of Nov 12, 2026 20:21 WIB: out of 150 priced stocks, 25 rose and 121 fell. Notable movers include CIFR at USD 6.67 with a 1-day change of -6.19% and Pluang order activity of 26% Sell / 74% Buy, DELL at USD 352.41 with a 1-day change of -5.70% and order activity 47% Sell / 53% Buy, and APLD at USD 16.98 with a 1-day change of -5.19% and order activity 15% Sell / 85% Buy.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
